FolioLanternBeta
IONSIonis Pharmaceuticals Inc

Kyle Jenne

EVP, Chf GL Pdt Str Ofcr at Ionis Pharmaceuticals Inc, as of Apr 17, 2026Sold $3.3M of stock in the past 12 months: 85% under a disclosed plan and 15% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
65%†
share of stake sold at Ionis Pharmaceuticals Inc
† Measured against shares held at the start plus shares received, because most of the shares sold arrived during the period.
24K
shares held after the latest filing, Ionis Pharmaceuticals Inc
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $138K to cover taxesJanFebMar 2026: $2.8M under a disclosed plan$2.8MMarApr 2026: $368K to cover taxesAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Ionis Pharmaceuticals Inc (IONS)EVP, Chf GL Pdt Str OfcrMar 13, 2024Apr 17, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.